---
DrugClass: "[[Antibacterial(Sulfonamides)]]"
DrugClassContra: "[[Antibacterial(Sulfonamides)#Contraindications]]"
DrugClassAdverse: "[[Antibacterial(Sulfonamides)#Side/Adverse Effects]]"
SubClass: "[[Single Agents]]"
SecondaryDrugClass: "[[Skeletal Muscle, Bone, and Joint Disorder Drugs]]"
SecondarySubClass: "[[Disease-modifying antirheumatic drugs (DMARDs)]]"
BrandName: Azulfidine
Chapter: "6"
KindleLinkChap: "[Chapter 6](kindle://book?action=open&asin=B09FRF11YJ&location=3015)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ThirdDrugClass: "[[Lower Gastrointestinal System Drugs]]"
ThirdSubClass: "[[Aminosalicylates]]"
SecondaryAdverse: "[[Disease-modifying antirheumatic drugs (DMARDs)#Adverse Reactions]]"
SecondaryContra: "[[Disease-modifying antirheumatic drugs (DMARDs)#Contraindications]]"
ThirdAdverse: "[[Aminosalicylates#Adverse Reactions]]"
ThirdContra: "[[Aminosalicylates#Contraindications]]"
SubCat: Aminosalicylates (5-ASA)
---
```smiles
OC(=O)c1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)ccc1O
```

### Brand name
`=this.BrandName`
### Generic name
`= this.file.name`
### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`
`= this.SecondaryDrugClass`
	`= this.SecondaryDrugClass.KindleLinkChap`
`= this.ThirdDrugClass`
	`= this.ThirdDrugClass.KindleLinkChap`
	
### Dosage & Usage
UTI, acute otitis media, H. influenzae
Initial therapy: 1â€“ 4 g/ day orally in divided doses
- maintenance dose: 2 g/ day orally in evenly spaced doses (500 mg QID)

### Contraindications
See `= this.DrugClassContra`
See `= this.SecondaryContra`
See `= this.ThirdContra`

### Interactionsde/Adverse Effects
See `= this.DrugClassAdverse`
See `= this.SecondaryAdverse`
See `= this.ThirdAdverse`
Same as [[sulfadiazine]]; may cause skin and urine to turn orange-yellow 

### Interactions
